A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer

NCT01217177 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Cervical Cancer

Interventions

DRUG: everolimus

Sponsor

Novartis Pharmaceuticals